Cargando…

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma

Tumor-associated macrophages, crucial components of the microenvironment in hepatocellular carcinoma, hamper anti-cancer immune responses. The aim of the present study was to investigate the effect of sorafenib on the formation of the tumor microenvironment, especially the relationship between polar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yan-Ru, Liu, Wen-Bin, Lian, Zhe-Xiong, Li, Xingsheng, Hou, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122390/ https://www.ncbi.nlm.nih.gov/pubmed/27203677 http://dx.doi.org/10.18632/oncotarget.9438

Ejemplares similares

Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
por: Chen, Weibo, et al.
Publicado: (2019)

Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Dong, Shuying, et al.
Publicado: (2015)

Corrigendum to: Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
Publicado: (2022)

SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Wang, Shanshan, et al.
Publicado: (2023)

Apatinib inhibits macrophage-mediated epithelial–mesenchymal transition in lung cancer
por: Liu, Shuliang, et al.
Publicado: (2018)

Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
por: Zhang, Juyong, et al.
Publicado: (2013)

KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification
por: Kuang, Ye, et al.
Publicado: (2022)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
por: Hu, Bo, et al.
Publicado: (2019)

Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
por: Yao, Ting, et al.
Publicado: (2022)

Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
por: Jia, Lining, et al.
Publicado: (2015)

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
por: Xu, Gui-Li, et al.
Publicado: (2020)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Liao, Li-Zhu, et al.
Publicado: (2020)

Protopanaxadiol inhibits epithelial–mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway
por: Yang, Lan, et al.
Publicado: (2019)

Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancer
por: de Araujo Junior, Raimundo Fernandes, et al.
Publicado: (2020)

MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Hirao, Akihiro, et al.
Publicado: (2021)

Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
por: Fouquet, Grégory, et al.
Publicado: (2022)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
por: Chen, Y-L, et al.
Publicado: (2013)

Reversal of TGF-β-induced epithelial–mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor
por: Modi, Siddharth J., et al.
Publicado: (2021)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma
por: Zhang, Deng-Yong, et al.
Publicado: (2020)

Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
por: Tian, Chuntao, et al.
Publicado: (2022)

Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5
por: Chen, Chi-Yuan, et al.
Publicado: (2018)

PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
por: Liu, Hongyu, et al.
Publicado: (2019)

MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X
por: Shen, Gang, et al.
Publicado: (2014)

Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
por: Jin, Bin, et al.
Publicado: (2016)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo
por: Xu, Chang-Geng, et al.
Publicado: (2019)

Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance
por: Zhang, Yan, et al.
Publicado: (2016)

miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
por: Gurzu, Simona, et al.
Publicado: (2019)

Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition
por: Scimeca, Manuel, et al.
Publicado: (2019)

Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition
por: Xu, Su, et al.
Publicado: (2017)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
por: Dong, Ningning, et al.
Publicado: (2019)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
por: Dong, Jiejie, et al.
Publicado: (2017)

The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
por: Adenina, Syarinta, et al.
Publicado: (2020)

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
por: Bonde, Anne-Katrine, et al.
Publicado: (2012)

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sfgr36o5nltn2e4026p2kifgv4